Take­da bless­es a lit­tle biotech's en­gi­neered tox­in tech for mul­ti­ple myelo­ma, trig­ger­ing a bases loaded home run

Austin-based Mol­e­c­u­lar Tem­plates scored three times on Wednes­day.

Ear­ly in the day the biotech an­nounced a deal with Take­da to take their 2 …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.